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E-mail address: giorgio.berton@univr.it (G. BertonCytoskeleton dynamics are regulated by Src-family tyrosine kinases (SFKs) and c-Abl. We found that
the SFK members Hck and c-Fgr regulate tyrosine phosphorylation of c-Abl and c-Abl associates
with b1 integrin-bound Hck or c-Fgr in murine macrophages. Studies with selective inhibitors and
cells from SFK-deﬁcient mice showed that c-Abl and SFK regulate migration and activation of the
small GTPases Cdc42 and Rac in macrophages. Additionally, human neutrophil chemotactic activity
was reduced by c-Abl inhibitors, and neutrophils from chronic myeloid leukaemia patients dis-
played an increased chemotactic ability. Hence, Src-family kinase and c-Abl cross-talk in the regu-
lation of myeloid cell migration.
Structured summary:
MINT-7296608: Integrin beta-1 (uniprotkb:P09055) physically interacts (MI:0914) with Hck (uni-
protkb:P08103), Abl (uniprotkb:P00520) and Fgr (uniprotkb:P14234) by anti bait coimmunoprecipitation
(MI:0006)
MINT-7296596: Integrin beta-1 (uniprotkb:P09055) physically interacts (MI:0914) with Fgr (uni-
protkb:P14234) and Abl (uniprotkb:P00520) by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Src-family kinases (SFKs) are implicated in signal transduction
by different surface receptors in haematopoietic cells [1]. In mye-
loid leukocytes, these kinases regulate different cell responses
[1,2] and genetic inactivation of Hck, c-Fgr and Lyn, the SFKs pre-
dominantly expressed in these cells, results in defective integrin-
dependent spreading, polarization and migration [2–5]. Similarly
to classical immune receptors, signaling by adhesive receptors
(integrins or the endothelial selectin counter-receptor PSGL-1) in
phagocytic cells involves, besides SFKs and Syk, the immunorecep-
tor tyrosine activation motif (ITAM)-containing adaptors DAP12
and FcRc [6–8]. Because signal transduction by the T cell receptor
(TCR) via a SFK/ITAM-containing adaptor/Zap70 module requires
c-Abl [9,10], we addressed whether c-Abl is implicated in signal
transduction by myeloid leukocyte non-immune receptors. Here
we report that c-Abl associates to integrin-bound c-Fgr or Hck
and its phosphorylation is regulated by these SFKs. Additionally,
we show that inhibition of c-Abl activity results in a marked reduc-chemical Societies. Published by E
thology, University of Verona,
8027127.
).tion of mouse macrophage and human neutrophil migration and
polarization. These ﬁndings suggest that cross-talk between SFKs
and c-Abl plays a critical role in regulation of myeloid cell
migration.2. Materials and methods
2.1. Cell isolation and culture
Bone marrow-derived macrophages (BMDMs) were isolated
from femurs and tibias of 6- to 8-week-old wild-type, hck/
fgr/ double and hck/ and fgr/ single knockout mice
(see [4]), backcrossed 4 generations into the wild-type C57BL/6J
strain [4]. Cells were resuspended in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) with Glutamax (Biowhittaker, Walkersville,
MD) supplemented with 15% FCS, 10% L-cell conditioned medium
(LCM) as a source of CSF-1, 100 U/ml penicillin, and 100 lg/ml
streptomycin (BMDMs complete medium), and cultured at 37 C/
5% CO2 in 75 cm2 ﬂasks. After 24 h, the non-adherent cells were re-
moved, counted and plated on bacteriologic (non-tissue culture
treated) plastic dishes in the above medium. Human PMNs were
prepared from buffy coats of healthy volunteers or from peripherallsevier B.V. All rights reserved.
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The murine wild-type (pSrl) pro-B lymphocyte cell line BaF3 was
cultivated at 37 C/5% CO2 in RPMI 1640 medium containing 10%
foetal bovine serum and 10% WEHI-3B-conditioned medium as a
source of IL-3 [11]. BaF3 cells expressing Bcr/Abl (BaF3/p210wt)
or Bcr-Abl with the T315 mutation (Baf3/T315) were cultured in
RPMI 1640 medium with 10% foetal bovine serum, without any
source of IL-3.
2.2. Antibodies and reagents
Antibodies were obtained from the following sources: anti-
phosphotyrosine mAb (4G10), UBI (Lake Placid, NY), anti-SFKs
(reactive with Src, Yes, Fyn and c-Fgr) and anti-Abl, Santa Cruz Bio-
technology Inc. (Santa Cruz, CA), anti-b1 and anti-b2 integrin,
Chemicon International (California, USA).
2.3. Cell migration assay
In vitro wound-healing assays were performed as described
[4,5] in the presence of 100 ng/ml lysophosphatidic acid (LPA) inFig. 1. c-Abl is a substrate of SFKs in BMDM and binds to c-Fgr or Hck complexed to the
lysed and anti-c-Abl immunoprecipitates (IP) separated on SDS/PAGE gels. Proteins were
One representative experiment of 2–4 performed is reported. (B and C) BMDM lysates w
described above with Abs of the indicated speciﬁcity (WB). WT, wild-type BMDM; HF
reported.medium supplemented or not with imatinib mesylate (STI;
10 lM; Novartis Pharma), bosutinib (SKI; 10 lM; Wyeth) or PP2
(10 lM). The number of cells migrating into the open space was
counted microscopically [5]. Neutrophil migration assays were
performed as previously described [12] using FCS-coated 3 lm
transwells.
2.4. Protein immunoprecipitation and immunoblotting
BMDMwere lysed in RIPA buffer (50 mM Tris (pH 7.5), 150 mM
NaCl, 1% (v/v) Triton X-100, 1% Na-deoxycholate, 0.1% sodium
dodecyl sulfate (SDS), 5 mM EDTA, 1 mM DTT, 100 lM Na2VO4,
10 lM phenilarsine oxide (PAO) and one tablet of CompleteTM Mini
EDTA-free protease inhibitor cocktail from Roche Molecular Bio-
chemicals for each 10 ml lysis buffer). After clariﬁcation in a micro-
fuge, lysates were incubated with 2 lg of Abs bound to 10 ll of
protein A or protein G immobilized to Trysacryl (Sigma) for each
sample and precipitated proteins washed three times with RIPA
buffer. Immunoprecipitated proteins or proteins in whole-cell ly-
sates were electrophoresed on SDS–polyacrylamide gel (SDS–
PAGE) and transferred to nitrocellulose for 90 min at 70 V. Filtersb1 integrin chain. (A) BMDM, isolated and cultivated as described in Section 2, were
blotted on nitrocellulose and blots probed with Abs of the indicated speciﬁcity (WB).
ere incubated with anti-b1 integrin Ab and immunoprecipitates (IP) processed as
/, hck/fgr/ BMDM. Two representative experiment of three performed are
Fig. 2. Macrophage migration requires the c-Abl kinase activity. (A–D) BMDM monolayers were wounded with the tip of a pipette and, after washing, added with medium
supplemented with 100 ng/ml LPA without (A, B) or plus 10 lM imatinib mesylate (STI) (C) or 10 lM PP2 (D). Monolayers were photographed immediately after the wound
(A) or after 6 h from wounding (B–D). (E) Cells migrated into the wound were quantiﬁed after different time from wounding. (F) BMDMwere incubated with control medium
(–) or medium supplemented with 10 lM imatinib mesylate (STI) or 10 lM PP2 for 30 min before lysis. To detect phosphorylation of SFKs, lysates were separated on SDS/
PAGE gels, proteins blotted on nitrocellulose and blots probed with Abs of the indicated speciﬁcity (WB). To detect c-Abl tyrosine phosphorylation, BMDM were lysed in RIPA
buffer as described in Section 2 and immunoprecipitated (IP) with anti-Abl Abs before blotting. (G) BMDMwere incubated with control medium (–) or medium supplemented
with 10 lM imatinib mesylate (STI) or 10 lM PP2 for 30 min before lysis. (H) Phase contrast images of cells at the margin of the wound after 2 h are shown. These were taken
at 40magniﬁcation with an Olympus IX50 microscope and acquired with an Olympus c-7070 wide zoom Digital compact camera. Inhibitors were used at the concentration
reported above. One typical of several experiment performed is reported. (I) Baf3 cells expressing Bcr/Abl are strongly polarized. Baf3 cells transfected with an empty vector
(Baf3/pSrl) or a vector containing wild-type Bcr/Abl (Baf3/p210wt) or Bcr-Abl with the T315 mutation (Baf3/T315) were cultivated and incubated with STI (10 lM) or PP2
(10 lM) as described in Section 2. Morphology of cells either untreated or treated with STI or PP2 is shown. Cells were plated in 24 well plates in RPMI 1640 medium
containing 10% FBS and phase contrast images at 40 magniﬁcation taken as described in the legend.
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Fig. 3. SFKs an c-Abl regulate Cdc42 and Rac activation. BMDM were isolated, cultivated and lysed as described in Section 2. GTP-bound Cdc42 and Rac were assayed after
30 min of incubation with 100 ng/ml LPA without or with 10 lM imatinib mesylate as described in Section 2 and mean result of three independent experiments are shown.
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Biosciences, Nebraska, USA) using speciﬁc antibodies. For analysis
of tyrosine phosphorylated proteins with phospho-speciﬁc Abs,
cells were lysed with sample buffer: 25 mM Tris, pH 6.8, 50 mM
b-mercaptoethanol, 1% SDS and 5% glycerol.2.5. Cdc42 and Rac activity assay
Cdc42 and Rac activity was assayed using EZ-Detect Rac activa-
tion kit according to the manufacturer instructions (Pierce Chemi-
cal; Thermo Fisher Scientiﬁc; Rockford, IL). Proteins were
separated by SDS–PAGE and, after blotting, membranes were
probed with anti-Cdc42 and anti-Rac Abs.3. Results
3.1. c-Abl binds to and is phosphorylated by SFKs in mononuclear
phagocytes
A bi-directional cross-talk between SFKs and c-Abl, or the onco-
protein Bcr-Abl, has been demonstrated in several studies [9,13–
18]. Examining c-Abl tyrosine phosphorylation in BMDMwe found
the constitutive, phosphorylation of c-Abl was much more robust
in wild-type compared to hck/fgr/ cells (Fig. 1A). Because
SFKs interact with integrins [19], we asked whether integrin-
bound SFKs associate with c-Abl. We found that c-Fgr and/or Hck
associate with the b1 (Fig. 1B and C) or the b2 (not shown) integrin
chain in wild-type BMDM lysates. Comparing b1 integrin-associ-
ated c-Abl in wild-type, fgr/, hck/ or hck/fgr/ BMDM
lysates (Fig. 1B and C), we found that only in the absence of both
c-Fgr and Hck expression c-Abl association with the b1 integrin
chain was undetectable, thus suggesting that c-Abl interacts witheither integrin-bound c-Fgr or Hck. A tripartite complex between
c-Fgr or Hck and c-Abl was also detectable in anti-b2 immunopre-
cipitates (not shown).
3.2. c-Abl regulates mononuclear phagocyte migration
Because c-Fgr and Hck associate with c-Abl and regulate its ex-
tent of tyrosine phosphorylation (Fig. 1) we addressed whether c-
Abl is implicated in a SFK-dependent signaling network regulating
macrophage migration [2]. Wild-type BMDM repair a wound gen-
erated by scratching a conﬂuent cell monolayer with a pipette tip
in a few hours (Fig. 2A and B), and the chemoattractant LPA hastens
it (data not shown). The c-Abl speciﬁc inhibitor imatinib mesylate
(STI) [20] or the Src speciﬁc inhibitor PP2 inhibited BMDM migra-
tion in this assay (Fig. 2C–E). To exclude that, in our assays, STI af-
fected also SFKs we used an Ab reacting with a phosphorylated
tyrosine residue (Y416) of the kinase domain of Src and other
SFK members (Fig. 2F). While treatment with PP2 of wild-type
BMDM or deﬁciency of Hck and c-Fgr expression markedly reduced
the reactivity of the anti-phospho Y416 antibody, STI did not affect
the intensity of the detected signal (Fig. 1F) as expected from its
inability to inhibit SFKs [20]. In contrast, both STI and PP2 mark-
edly inhibited c-Abl tyrosine phosphorylation (Fig. 1F). Comparing
the effect of the two inhibitors on the total tyrosine phosphoryla-
tion signal (Fig. 1G) we found that, whereas treatment with PP2
or deﬁciency of Hck and c-Fgr resulted in a marked inhibition of
tyrosine phosphorylation of several proteins, STI did not affect this
signal. We conclude that in BMDM SFKs phosphorylate a wide ar-
ray of substrates, including c-Abl, and c-Abl downstream targets
include a more limited number of proteins, some of which play a
key role in regulating cell migration.
A closer view of cells at the margin of the wound showed that
wild-type BMDM acquire an elongated morphology protruding
Fig. 4. c-Abl regulates human neutrophil migration and polarization. (A) Neutrophils were incubated with 1 lM imatinib (STI) or bosutinib (SKI) for 30 min before transfer to
the upper compartment of 3 lm pore transwells. Neutrophils migrated to the lower compartment of the transwell that contained or not (Ctr) 100 nM fMLP were quantiﬁed
after 60 min. Mean results ± S.D. of three independent experiments are reported. (B) Control or imatinib (STI)-treated neutrophils were stimulated with 100 nM fMLP for
5 min. (C) Neutrophils from healthy donors or ﬁrst diagnosis CML patients were assayed as in (A).
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cells treated with imatinib remained rounded and showed no sign
of polarization. Such a circular, multipolar morphology was re-
ported to be a feature of macrophages with the genetic inactivation
of c-Fgr and Hck or some of their substrates (see [2] for a discus-
sion of this topic). PP2 caused a more profound alteration of BMDM
morphology also inducing reduction of cell spreading and cell
detachment from the adherent surface (Fig. 2H). We conclude that
c-Abl is an essential component of a SFK-based signaling network
regulating macrophage polarization and migration. In order to
strengthen the conclusion that c-Abl regulates cell polarization
and this requires its kinase activity, we examined the murine
hematopoietic cell line Baf3 expressing wild Bcr-Abl or Bcr-Abl
with the T315 mutation that inhibit imatinib binding. As shown
in Fig. 2I, compared with the same cell line transfected with an
empty vector, Bcr-Abl expressing cells are strongly polarized and
both imatinib and PP2 reverted this phenotype to a circular mor-
phology. Interestingly, the constitutive polarized phenotypes of
Baf3 cells expressing Bcr-Abl with the T315 mutation was not re-versed by imatinib, but only by PP2. These ﬁndings suggest that
SFKs and c-Abl are both required to regulate cell polarization but,
in line with their predominant role on tyrosine phosphorylation
signals (Fig. 1G) and functional responses in macrophages
(Fig. 2H), SFKs play an essential role also in cells expressing the
constitutively active Bcr-Abl oncoprotein.
3.3. c-Abl and SFKs regulate Cdc42 and Rac activation
Because oncogenic forms of c-Abl have been reported to regu-
late actin dynamics in a manner dependent on the small GTPase
Rac [15,21,22], we asked whether regulation of macrophage migra-
tion by c-Abl depended on Rac or Cdc42, another RhoGTPase impli-
cated in actin polymerization and membrane protrusive activity.
As shown in Fig. 3, the chemoattractant LPA increased the amount
of active, GTP-bound Cdc42 and Rac in BMDM. Imatinib mesylate
markedly reduced both GTP-bound Cdc42 and Rac levels 30 min
following stimulation. Consistent with previous reports demon-
strating that SFK-deﬁcient macrophages display a reduced
20 A. Baruzzi et al. / FEBS Letters 584 (2010) 15–21migratory ability [4,5], Cdc42 and Rac activation were lower both
in unstimulated and LPA-treated hck/fgr/ BMDM and further
reduced by imatinib mesylate.
3.4. c-Abl regulates polarization and migration of normal and CML
human neutrophils
Having implicated c-Abl in regulation of murine macrophage
polarization and migration, we asked whether it also regulates hu-
man myeloid cell migratory ability. In a standard 3 lM pore trans-
well assay fMLP-induced neutrophil migration was markedly
inhibited by both imatinib mesylate and by bosutinib, an inhibitor
displaying a dual speciﬁcity for SFKs and c-Abl [23] (Fig. 4A). Inhi-
bition of c-Abl also hampered the capability of fMLP to trigger a
polarized phenotype (Fig. 4B). Importantly, comparing neutrophils
from control subjects and ﬁrst diagnosis patient with Philadelphia-
positive CML expressing Bcr-Abl, we found that fMLP-induced che-
motactic migration of CML neutrophils was markedly higher
(Fig. 4C).4. Discussion
SFKs are essential components of a signal transduction pathway
regulating macrophage cytoskeleton dynamics [2–7]. The genetic
deﬁciency of SFKs [3,4] or some of their substrates and/or interact-
ing proteins such as Pyk2, FAK and c-Cbl results in profound alter-
ations in macrophage morphology, polarization and migration
(reviewed in [2]).
Implication of SFKs in macrophage migratory ability has been
linked to their role in signal transduction by integrins [2–4]. Inte-
grin signaling in phagocytic cells has been shown to be similar to
immune receptor signaling and based on a SFK/ITAM-containing
adaptor/Syk module (reviewed in [7,24]). Noteworthy, c-Abl has
been placed in between SFKs and Zap-70 in TCR-mediated signal
transduction leading to T-cell activation [9] and the formation of
the T-cell immunological synapse [10]. Additionally, c-Abl was re-
cently implicated in regulation of b2 integrin-mediated neutro-
phil adhesion [25]. Our results extend these observations
supporting the conclusion that c-Abl is an essential downstream
target of a SFK-mediated integrin signaling network in phagocytic
cells.
Macrophage chemokinetic migration and neutrophil chemo-
taxis in response to different chemoattractants depends on the c-
Abl kinase activity (Figs. 2 and 4). Notably, c-Abl was recently
shown to positively regulate chemokine-induced T cell migration
[10]. These results are in line with the evidence that Bcr-Abl in-
creases spontaneous, chemokinetic migration of both CD34+ hema-
topoietic precursors [16] and Baf3 cells [11]. Additionally, the
ﬁndings that CML neutrophils display an enhanced migratory abil-
ity may explain alteration in adhesion and trafﬁcking of CML cells
[26].
Several reports implicated c-Abl in regulation of cytoskeleton
dynamics underlying membrane rufﬂing, ﬁlopodia formation and
lamellipodia protrusion [10,15,21,22,27]. Consistent with their
essential role in regulating actin polymerization, Rho GTPases have
been placed downstream the Abl/Arg family of tyrosine kinases in
signal transduction to the cytoskeleton (see [21,22,25,27]). Consis-
tent with these studies, we found that stimulation of macrophage
chemokinesis by LPA was accompanied by Cdc42 and Rac activa-
tion and this depended on both c-Abl kinase activity and SFK
expression (Fig. 3).
Stimulation through both chemoattractants and integrin adhe-
sive receptors play a coordinated, essential role in mediating mye-
loid cell migration (see [2]). We hypothesize that the most
upstream component of the integrin signaling pathway is repre-sented by a complex formed by a SFK (either Hck or c-Fgr) and c-
Abl. Signals via this complex seem to be indispensable also for re-
sponses to chemoattractants. These ﬁndings suggest that Abl-spe-
ciﬁc or Abl-Src dual speciﬁc inhibitors may represent new drugs to
control leukocyte recruitment into inﬂammatory lesions.
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